- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2012410 3 comments science
- Patients hospitalized with Covid-19 who received hydroxychloroquine did not have a lower incidence of death at 28 days than those who received usual care. (n=1561, randomized, controlled, open-label platform trial, NEJM, 8 Oct 2020) https://www.nejm.org/doi/full/10.1056/nejmoa2022926 8 comments science